Literature DB >> 15000828

The apparent uptake of fluorescently labeled siRNAs by electroporated cells depends on the fluorochrome.

Jenny Dunne1, Bettina Drescher, Heidemarie Riehle, Philipp Hadwiger, Bryan D Young, Jürgen Krauter, Olaf Heidenreich.   

Abstract

Transfection of mammalian cells with preformed small interfering RNAs (siRNAs) permits a transient and often specific reduction of gene expression. It is possible to rapidly examine the uptake of siRNAs by transfection with fluorescently labeled siRNAs. We examined the apparent uptake of such siRNAs by several leukemic cell lines after electroporation. We show that Cy3 and Cy5-labeled siRNAs cause a significant amount of cell fluorescence, as judged by flow cytometry. In contrast, several fluorescein-labeled siRNAs could not be detected. Nevertheless, such fluoresceinated siRNAs efficiently suppressed a leukemic target gene, demonstrating that siRNA uptake must have taken place. Therefore, for cell electroporation, fluorescein-labeled siRNAs may lead to false negative results and should not be used to examine electroporation-mediated siRNA uptake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15000828     DOI: 10.1089/154545703322617050

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  9 in total

1.  Targeting of gene expression by siRNA in CML primary cells.

Authors:  Michaela Merkerova; Hana Klamova; Radim Brdicka; Hana Bruchova
Journal:  Mol Biol Rep       Date:  2006-11-09       Impact factor: 2.316

Review 2.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Authors:  Miles A Miller; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2016-06-04       Impact factor: 15.470

3.  High-throughput RNAi screening in vitro: from cell lines to primary cells.

Authors:  Dmitriy Ovcharenko; Richard Jarvis; Scott Hunicke-Smith; Kevin Kelnar; David Brown
Journal:  RNA       Date:  2005-06       Impact factor: 4.942

4.  Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.

Authors:  Bruno M D C Godinho; James W Gilbert; Reka A Haraszti; Andrew H Coles; Annabelle Biscans; Loic Roux; Mehran Nikan; Dimas Echeverria; Matthew Hassler; Anastasia Khvorova
Journal:  Nucleic Acid Ther       Date:  2017-10-12       Impact factor: 5.486

5.  Microporation is an efficient method for siRNA-induced knockdown of PEX5 in HepG2 cells: evaluation of the transfection efficiency, the PEX5 mRNA and protein levels and induction of peroxisomal deficiency.

Authors:  Barbara Ahlemeyer; Julia-Franziska Vogt; Vera Michel; Petra Hahn-Kohlberger; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2014-09-17       Impact factor: 4.304

6.  Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics.

Authors:  Mark Stevenson; Robert Carlisle; Ben Davies; Chris Preece; Michelle Hammett; Wei-Li Liu; Kerry David Fisher; Amy Ryan; Heidi Scrable; Leonard William Seymour
Journal:  Mol Ther Nucleic Acids       Date:  2013-11-19       Impact factor: 10.183

7.  Establishment of a positive-readout reporter system for siRNAs.

Authors:  Wei-Li Liu; Douglas P Owen; Kerry D Fisher; Leonard W Seymour; Mark Stevenson
Journal:  J RNAi Gene Silencing       Date:  2009-06-12

8.  The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.

Authors:  Natalia Martinez; Bettina Drescher; Heidemarie Riehle; Claire Cullmann; Hans-Peter Vornlocher; Arnold Ganser; Gerhard Heil; Alfred Nordheim; Jürgen Krauter; Olaf Heidenreich
Journal:  BMC Cancer       Date:  2004-08-06       Impact factor: 4.430

9.  The Non-Specific Binding of Fluorescent-Labeled MiRNAs on Cell Surface by Hydrophobic Interaction.

Authors:  Ting Lu; Zongwei Lin; Jianwei Ren; Peng Yao; Xiaowei Wang; Zhe Wang; Qunye Zhang
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.